Research Category

Asia Pacific Biotechnology Market (2008-2012) 2008-8-19 11:0

Publisher:

Published:

August 2008

Format:

PDF

Price:

US$1600.00 Single User PDF

Pages:

110

Key Words:

Asia Pacific Biotechnology

Are you interested in custom research?(click here)

Report Summary

The report "Asia Pacific Biotechnology Market (2008-2012)" provides an exhaustive view of the biotechnology markets in the Asia-Pacific region (Japan, China, Australia, South Korea, India, Taiwan, New Zealand and Singapore). It also provides a detailed account of the major factors driving growth in the biotechnology industry of the region and enabling it to become a dominant force in the future.

As per our research, countries in the Asia-Pacific region were late starters in the biotechnology market. However, the industry is growing much faster than the industries in North America and Europe, primarily due to low costs, strong government support, large talent pool and biodiversity. In future both India and China are expected to emerge as leading players in the global biotechnology market.

Information on the market size, structure, segmentation, growth, future forecasts, success and risk factors and evolving trends in technology development are thoroughly analyzed in this report.

The report also covers the fact that the biotechnology markets in the Asia-Pacific region have huge differences from one another in terms of infrastructure, funding, talent pool, growth, size and potential as an outsourcing destination. Thus, it provides valuable information to pharmaceutical & biotechnology companies and investors looking to enter these markets and help them to devise strategies in accordance to the individual markets.

Key Findings

* Growing at an estimated CAGR of 15.9% between 2005 and 2007, the value of Asia-Pacific Biotechnology market in 2007 was more than US$ 41 Billion.
* Japan, China, and Australia are the three largest biotechnology markets in the Asia-Pacific region, with combined market share of around 79% in 2007. The medical biotechnology sector presently accounts for the highest share in the overall market.
* Japan remains the largest biotech market in the region; therefore, the country represents a more mature market as compared to other neighboring markets.
* China and India, with low costs and big talent pool, are likely to emerge as the most potential biotech research and manufacturing outsourcing destinations in the future.
* Asia-Pacific is expected to become a major destination for stem cell research and biogeneric manufacturing.

Key Issues and Facts

The research report addresses the issues and facts critical to success in the emerging biotechnology industry in Asia-Pacific:

* What are the market trends in the Asia-Pacific Biotechnology industry?
* An insight into the biotechnology industries of Japan, China, India, South Korea, Australia, Taiwan, New Zealand and Singapore.
* An overview of Bioclusters in the Asia-Pacific Biotechnology industry.
* Key sectors in the Asia-Pacific Biotechnology industry.
* Course of market growth for the next 5 years.
* Opportunities that can be leveraged by the Asia-Pacific Biotechnology industry.
* Forces that are driving the biotechnology industry in the Asia-Pacific region.
* Challenges faced by the Asia-Pacific Biotechnology industry.

Research Methodology

Information Sources
Information has been sourced from various authentic and reliable sources like books, newspapers, trade journals & white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.

Analysis Methods
The analysis methods comprise of Ratio Analysis, Historical Trend Analysis, Linear Regression Analysis (using software tools), Judgmental Forecasting, and Cause and Effect Analysis.

Report Outline

1. Analyst View
2. Global Biotechnology Industry Overview
     2.1 Market Overview
            2.1.1 Product Segmentation
            2.1.2 Geographical Segmentation
3. Asia-Pacific Biotechnology Market
     3.1 Market Overview
            3.1.1 Product Segmentation
            3.1.2 Geographical Segmentation
     3.2 What Makes Asia-Pacific Biotech Market Capable?
            3.2.1 Strong Government Support
            3.2.2 Human Resources
            3.2.3 Bio-diversity
            3.2.4 Infrastructure
            3.2.5 Low Cost
4. Asia-Pacific Biotechnology Market by Country
     4.1 Japan
            4.1.1 Market Overview
            4.1.2 Product Segmentation
            4.1.3 Bio-clusters
            4.1.4 Success & Risk Factors
                      4.1.4.1 Success Factors
                      4.1.4.2 Risk Factors
            4.1.5 Future Outlook (2008-2012)
     4.2 China
            4.2.1 Market Overview
            4.2.2 Product Segmentation
            4.2.3 Bio-clusters
            4.2.4 Success & Risk Factors
                      4.2.4.1 Success Factors
                      4.2.4.2 Risk Factors
            4.2.5 Future Outlook (2008-2012)
     4.3 India
            4.3.1 Market Overview
            4.3.2 Product Segmentation
            4.3.3 Bio-clusters
            4.3.4 Success & Risk Factors
                      4.3.4.1 Success Factors
                      4.3.4.2 Risk Factors
            4.3.5 Future Outlook (2008-09 to 2012-13)
     4.4 Australia
            4.4.1 Market Overview
            4.4.2 Bio-clusters
            4.4.3 Success & Risk Factors
                      4.4.3.1 Success Factors
                      4.4.3.2 Risk Factors
            4.4.4 Future Outlook (2008-09 to 2012-13)
     4.5 Taiwan
            4.5.1 Market Overview
            4.5.2 Bio-clusters
            4.5.3 Success & Risk Factors
                      4.5.3.1 Success Factors
                      4.5.3.2 Risk Factors
            4.5.4 Future Outlook (2008-2012)
     4.6 South Korea
            4.6.1 Market Overview
            4.6.2 Product Segmentation
            4.6.3 Bio-clusters
            4.6.4 Success & Risk Factors
                      4.6.4.1 Success Factors
                      4.6.4.2 Risk Factors
            4.6.5 Future Outlook (2008-2012)
     4.7 New Zealand
            4.7.1 Market Overview
            4.7.2 Product Segmentation
            4.7.3 Bio-clusters
            4.7.4 Success & Risk Factors
                      4.7.4.1 Success Factors
                      4.7.4.2 Risk Factors
            4.7.5 Future Outlook (2008-2012)
     4.8 Singapore
            4.8.1 Market Overview
            4.8.2 Bio-clusters
            4.8.3 Success & Risk Factors
                      4.8.3.1 Success Factors
                      4.8.3.2 Risk Factors
            4.8.4 Future Outlook (2008-2012)
5. Emerging Sectors
     5.1 Contract Research/Manufacturing
     5.2 Vaccines
     5.3 Generics
     5.4 Stem Cell Research
     5.5 Nanotechnology
     5.6 Bioinformatics
6. Roadblocks
     6.1 Lack of IPR Regime
     6.2 Lack of Private Participation
     6.3 Lack of Bioventures
     6.4 Lack of Cash
7. Future Outlook
     7.1 Increased Government Support
     7.2 Role of Private Sector
     7.3 Improved Intellectual Property Regime
     7.4 Mergers & Acquisitions
     7.5 Infrastructure Improvement
     7.6 Sustained Growth in Revenues Through 2012
8. Competitive Landscape
     8.1 Invitrogen Corporation
     8.2 Takara Holdings, Inc.
     8.3 CSL Limited
     8.4 Biota Holdings Limited
     8.5 GlaxoSmithKline Plc

Figures

Figure 2-1: Global - Biotechnology Market (in Million US$), 2005-2007E
Figure 2-2: Global - Forecast for Biotechnology Market (in Million US$), 2008-2012
Figure 2-3: Global - Biotechnology Market by Segment (%), 2006
Figure 2-4: Global - Biotechnology Market by Region (%), 2006
Figure 3-1: Asia-Pacific* - Biotechnology Market (in Million US$), 2005-2007
Figure 3-2: Asia-Pacific - Biotechnology Market by Segment (%), 2006
Figure 3-3: Asia-Pacific - Biotechnology Market by Country (%), 2007
Figure 4-1: Japan - Biotechnology Market (in Billion JPY), 1998-2007
Figure 4-2: Japan - Biotechnology Market by Segment (in Billion JPY), 2005 & 2007
Figure 4-3: Japan - Biotechnology Market by Segment (%), 2005 & 2007
Figure 4-4: Japan - Medical & Healthcare Biotechnology Market by Segment (%), 2007
Figure 4-5: Japan - Geographical Distribution of Bio-Clusters
Figure 4-6: Japan - Forecast for Biotechnology Market (in Billion JPY), 2008-2012
Figure 4-7: China - Biotechnology Market (in Billion Yuan), 2005-2007E
Figure 4-8: China - Biotechnology Market by Segment (%), 2006
Figure 4-9: China - Forecast for Biotechnology Market (in Billion Yuan), 2008-2012
Figure 4-10: India - Investments in Biotechnology Market (in Million US$), 2001-02 to 2007-08
Figure 4-11: India - Biotechnology Market (in Billion INR), 2002-03 to 2007-08E
Figure 4-12: India - Exports & Domestic Consumption of Biotechnology Market (%), 2006-07
Figure 4-13: India - Biotech Companies by Segment (%), 2006-07
Figure 4-14: India - Biotechnology Market by Segment (%), 2007-08E
Figure 4-15: India - Biopharmaceutical Market by Segment (%), 2006-07
Figure 4-16: India - Forecast for Biotechnology Market (in Billion INR), 2008-09 to 2012-13
Figure 4-17: India - Forecast for Biotechnology Market by Segment (%), 2012-13
Figure 4-18: Australia - Biotechnology Market (in Billion AU$), 1998-99, 2002-03 to 2007-08E
Figure 4-19: Australia - Geographical Distribution of Bio-clusters
Figure 4-20: Australia - Forecast for Biotechnology Market (in Billion AU$), 2008-09 to 2012-13
Figure 4-21: Taiwan - Investments in the Biotechnology Market (in Million US$), 2006 & 2007
Figure 4-22: Taiwan - Biotechnology Market (in Million US$), 2003-2007E
Figure 4-23: Taiwan - Forecast for Biotechnology Market (in Million US$), 2008-2012
Figure 4-24: South Korea - Biotechnology Market (in Million US$), 2002-2007E
Figure 4-25: South Korea - Biotechnology Market* by Segment (%), 2004
Figure 4-26: South Korea - Geographical Distribution of Bio-clusters
Figure 4-27: South Korea - Forecast for Biotechnology Market (in Million US$), 2008-2012
Figure 4-28: New Zealand - Biotechnology Market* (in Million NZ$), 1999 & 2004-2007E
Figure 4-29: New Zealand - Biotechnology Market* by Segment (%), 2005
Figure 4-30: New Zealand - Geographical Distribution of Bio-clusters
Figure 4-31: New Zealand - Forecast for Biotechnology Market (in Million NZ$), 2008-2012
Figure 4-32: Singapore - Biotechnology Market* (in Million US$), 2005-2007
Figure 4-33: Singapore - Forecast for Biotechnology Market (in Million US$), 2008-2012
Figure 5-1: India - Contract Research Market (in Million US$), 2002, 2006, 2007E & 2012F
Figure 5-2: India - Contract Manufacturing Market (in Millon US$), 2004, 2006, 2007E & 2012F
Figure 5-3: Global - Nanotechnology Applications in Life Sciences (in Billion US$), 2005E & 2010F
Figure 7-1: Asia-Pacific* - Forecast for Biotechnology Market (in Million US$), 2008-2012
Figure 7-2: Asia-Pacific - Forecast for Biotechnology Market by Country (%), 2012

Tables

Table 4-1: India - Top 20 Biotech Companies by Revenue (in Million INR), 2006-07
Table 4-2: South Korea - Growth in Major Segments of Biotechnology Market (%), 1999-2004trix

Future of Red Biotechnology in China 4-26 16:18

Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma 4-19 13:22

Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape 4-19 13:20

Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis 4-19 13:17

Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs 4-19 13:12

Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline 4-19 13:6

Booming Biotech Market in India 4-13 14:43

US Stem Cell Market Analysis 5-19 15:38